According to the Asociación Española contra el Cancer (AECC), an estimated one in two men and one in three women in Spain will face a cancer diagnosis during their lifetimes. To address this statistical reality, the AECC gathered researchers at the Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CiMUS) of the Universidade de Santiago de Compostela to highlight ongoing projects aimed at improving oncological diagnosis and treatment ahead of World Cancer Research Day.
The gathering, held on September 23, 2026, showcased local investigations supported by the association to tackle major challenges in modern oncology. Alfonsín noted that her professional path merged with her personal history following her father's death from a tumor, driving her transition from biology studies into cancer research.
Targeting Aggressive Hepatic and Brain Tumors
According to CiMUS researcher Alberto Tinahones, new studies are opening therapeutic opportunities for patients diagnosed with cholangiocarcinoma, a particularly aggressive liver cancer characterized by high mortality rates. Fellow CiMUS researcher Emma Ramos presented her work focusing on glioblastomas, which are the most common and malignant primary brain tumors found in adults. Ramos utilizes advanced imaging techniques to refine diagnostic accuracy, enabling more personalized and precise treatments for patients.
The event was moderated by Dr. Angélica Figueroa of the scientific committee for the AECC’s provincial board. Figueroa emphasized that the ultimate benchmark for these scientific endeavors is achieving a cancer survival rate of over 70 % by 2030. Currently, the AECC maintains 38 active research projects and grants in the province of A Coruña, representing an investment exceeding 5,3 million euros, which accounts for 88 % of the organization’s total funding dedicated to cancer research in Galicia.
Economic Relief and Future Impact for Patients
Researchers at the Santiago event highlighted the critical financial stability provided by the AECC grants. According to Tinahones, securing a contract funded for four years alleviates significant economic pressure that many standard laboratories cannot sustain independently. Ramos added that the primary goal remains translating laboratory findings into practical clinical benefits rather than merely accumulating publications, ensuring a direct impact on patient care.
The session also featured contributions from Dr. Ángel Carracedo and Xoán Concheiro, president of the AECC local board in Santiago. Through sustained local investment and targeted predoctoral grants, the association continues to bridge the gap between laboratory science and tangible improvements in patient survival and quality of life.